Cannabics Pharmaceuticals Inc. (CNBX) 0.2449 $CNBX
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Cannabics Pharmaceuticals engages with Mountain High Products in Colorado
PR Newswire - Thu Dec 18, 8:41AM CST
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has executed a letter of engagement with Mountain High Products in Colorado, for the manufacturing and distribution of Cannabics SR medical cannabis products in the Colorado market.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06)
Cannabics Pharmaceuticals Signs IP Licensing and Collaboration Agreement in Spain
Marketwired - Thu Nov 06, 7:32AM CST
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has executed an IP Licensing and Collaboration Agreement with Kalapa Holding (Spain) for the production and distribution of CANNABICS SR medical cannabis products in the Spanish market.
Cannabics Pharmaceuticals, Inc. to Present at Cannabis Investor Webcast
ACCESSWIRE - Mon Oct 27, 7:01PM CDT
Bethesda, MD / ACCESSWIRE / October 27, 2014 / Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) will be presenting at the Cannabis Investor Webcast on Tuesday, October 28, 2014 at 11:00 AM ET.
Cannabics Pharmaceuticals Receives Cannabinoid R&D Lab Certification in Israel
Marketwired - Mon Oct 20, 8:05AM CDT
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has received Government Certification from the Ministry of Health in Israel for the establishment of an advanced R&D laboratory dedicated to medical research in the field of cannabinoid science.
Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR
Marketwire - Fri Sep 26, 7:30AM CDT
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX), a developer of advanced medical cannabis therapies, announces that it has achieved Good Manufacturing Practices (GMP) capabilities as the Company moves toward the launch of its first clinical study of Cannabics SR capsules.
Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board
Business Wire - Tue Aug 19, 2:23PM CDT
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that the Company has made two key appointments to the Company's Advisory Board with the recent recruitment of Mr. Ika Abravanel as senior advisor in the field of operational and strategic planning, and Dr. Sigalit Ariely-Portnoy, as senior advisor in the field of regulation, validation and quality.
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Cannabics Pharmaceuticals engages with Mountain High Products in Colorado
PR Newswire - Thu Dec 18, 8:41AM CST
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has executed a letter of engagement with Mountain High Products in Colorado, for the manufacturing and distribution of Cannabics SR medical cannabis products in the Colorado market.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06)
Cannabics Pharmaceuticals Signs IP Licensing and Collaboration Agreement in Spain
Marketwired - Thu Nov 06, 7:32AM CST
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has executed an IP Licensing and Collaboration Agreement with Kalapa Holding (Spain) for the production and distribution of CANNABICS SR medical cannabis products in the Spanish market.
Cannabics Pharmaceuticals, Inc. to Present at Cannabis Investor Webcast
ACCESSWIRE - Mon Oct 27, 7:01PM CDT
Bethesda, MD / ACCESSWIRE / October 27, 2014 / Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) will be presenting at the Cannabis Investor Webcast on Tuesday, October 28, 2014 at 11:00 AM ET.
Cannabics Pharmaceuticals Receives Cannabinoid R&D Lab Certification in Israel
Marketwired - Mon Oct 20, 8:05AM CDT
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has received Government Certification from the Ministry of Health in Israel for the establishment of an advanced R&D laboratory dedicated to medical research in the field of cannabinoid science.
Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR
Marketwire - Fri Sep 26, 7:30AM CDT
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX), a developer of advanced medical cannabis therapies, announces that it has achieved Good Manufacturing Practices (GMP) capabilities as the Company moves toward the launch of its first clinical study of Cannabics SR capsules.
Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board
Business Wire - Tue Aug 19, 2:23PM CDT
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that the Company has made two key appointments to the Company's Advisory Board with the recent recruitment of Mr. Ika Abravanel as senior advisor in the field of operational and strategic planning, and Dr. Sigalit Ariely-Portnoy, as senior advisor in the field of regulation, validation and quality.
